Erratum: Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection (BJU International (2009) 103 (1368-1374))

Yair Lotan, U. Capitanio, S. F. Shariat, G. C. Hutterer, P. I. Karakiewicz

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Erratum: Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection (BJU International (2009) 103 (1368-1374))'. Together they form a unique fingerprint.